Clinical Trials Logo

Fatigue clinical trials

View clinical trials related to Fatigue.

Filter by:

NCT ID: NCT03940911 Not yet recruiting - Fatigue Clinical Trials

Fatigue and Skeletal Muscle Impact in Severe Axial Spondyloarthritis

Famuspa
Start date: September 17, 2024
Phase: N/A
Study type: Interventional

Axial spondyloarthropathy (SpA) is the most common inflammatory rheumatism (1% of the general population) with important medico-economic consequences. Fatigue is a major feature of SA. It can be defined as a feeling of reduced muscle capacity, lack of energy and exhaustion. The fatigue reaches an abnormally high level (fatigue severity score (FSS) ≥4, called severe fatigue in this protocol) in more than two thirds of patients with SA. Skeletal muscle repercussions are present during SA. It is characterized by a decrease in exercise capacity independently of pain and ankylosis but is associated with a decrease in strength and muscle mass, the importance of which varies from one study to another. The link between fatigue (subjective sensation) and the skeletal muscular impact (objective) of SA has never been studied.

NCT ID: NCT03837886 Not yet recruiting - Fatigue Clinical Trials

Effects of Sodium Bicarbonate Supplementation on Intermittent and Intense Task

Start date: October 20, 2019
Phase: N/A
Study type: Interventional

The aim of this study was to verify if sodium bicarbonate (NaHCO3) suplementation promotes changes in the performance, muscular activity and strength of individuals trained during the intermittent and intense task . Twelve trained adult men will participate in this randomized, double-blind, crossover clinical trial. Each participant should receive two types of intervention with a 14-day interval between conditions: alkalosis (ALK) in which gelatinous capsules containing 0.3 g.kg -1 of NaHCO 3 and placebo (PLA) are administered, in which 0.3 g.kg-1 of Calcium Carbonate (CaCO3). The following results will be considered: electromyographic activity (EMG) of the quadriceps muscle, peak torque, pH, lactate, and perception of effort, recovery and pain questionnaires, which will be collected during intermittent and high intensity DI protocol. ANOVA of repeated measures will be used to verify possible differences between groups.

NCT ID: NCT03817073 Not yet recruiting - Multiple Sclerosis Clinical Trials

Assessing Fatiguability of Tongue Muscles in MS

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

Multiple Sclerosis (MS) patients with subjective dysphagia will be tested for tongue strength fatigue using a strictly defined fatigue paradigm. A maximum of 40 sets will be performed, each set consisting of 5 repetitions of 80% of maximum isometric pressure (MIP) at the anterior tongue, followed by a MIP at the anterior tongue. Cut-off criteria are a MIP <50% of the baseline MIP, pronounced subjective discomfort and/or exceeding the allocated test time of 30 minutes.

NCT ID: NCT03735654 Not yet recruiting - Multiple Sclerosis Clinical Trials

Multi-joint Muscle Fatigability and Gait Performance in People With Multiple Sclerosis

MS_Gait
Start date: November 15, 2018
Phase:
Study type: Observational

The purpose of this study is to compare walking to leg strength and endurance in people with multiple sclerosis (PwMS). Using these findings, we hope to be better understand what causes PwMS to have problems walking.

NCT ID: NCT03728231 Not yet recruiting - Rheumatic Diseases Clinical Trials

Disease Activity in RA and SLE Patients and Its Relation to Muscle Performance,Fatigue and Blood Parameters

Start date: November 15, 2018
Phase:
Study type: Observational

Assessment of disease activity in Rheumatoid Arthritis and Systemic lupus patients related to muscle performance, fatigue and blood parameters

NCT ID: NCT03497468 Not yet recruiting - Clinical trials for Multiple Sclerosis, Relapsing-Remitting

Effects of Task-oriented Training on Functional Mobility and Fatigue in Patients With Multiple Sclerosis

Start date: April 2018
Phase: N/A
Study type: Interventional

Multiple Sclerosis (MS) is inflammatory, demyelinating and autoimmune disease of the central nervous system. It is usually seen with relapses and genetic and environmental factors play a role in the etiology. Neurological symptoms seen in MS restrict the patient's daily activity and social role participation. Mobility problems and fatigue are the most important reasons of role limitations and decreased quality of life. The importance of exercise training in disease management has been emphasized in recent years. However, few studies have investigated the effects of task-oriented trainings on symptoms of the disease. The aim of this sudy is to investigate the effects of task-oriented training additional to combined exercise training on functional capacity, mobility, balance, fatigue and quality of life in patients with MS.

NCT ID: NCT03491501 Not yet recruiting - Mental Fatigue Clinical Trials

Wearable Robotic Upper Body Exoskeleton for Workers

Exo4Work
Start date: July 16, 2018
Phase:
Study type: Observational

The main aim of the project is to evaluate a novel upper body exoskeleton during simulated industrial work. In a first stage of the project, an extensive study involving the end-user companies will be carried out to clearly identify the operator target tasks and typical target task loads for which the exoskeleton will be designed. Based on standard ergonomic evaluation scales (RULA and NIOSH, the Need for Recovery Scale and the Ovako Working Posture Analysing System), high risk tasks will be identified in the field, based on the evaluated information about the workspace configuration, the performed operations and their physical constraints. These will include, but will not be limited to, non-ergonomic postures, for example performing operations above the head or reaching in front, to the side, or behind the body; flexing the arms for extended periods of time; and bending or twisting the torso to lift an object from low or distant locations. Important items to assess in this task are the frequency and duration of tasks and activities, lifting characteristics, perceived physical effort and work-induced fatigue.

NCT ID: NCT03354871 Not yet recruiting - Fatigue Clinical Trials

Developing Models for Fatigue Monitoring in Obstetrics and Gyne- Cology Residents Using Wearables

IoT4Resident
Start date: November 2017
Phase: N/A
Study type: Observational

This study is set out to observe heart-rate and related bio-metric indicators in Obstetrics and Gynecology residents during their duty hours, together with self-reporting of fatigue and tasks performances, in order to model possible relationships between the two.

NCT ID: NCT03331419 Not yet recruiting - Clinical trials for Chronic Fatigue Syndrome

Exercise-related Post-exertional Malaise

CFS/ME
Start date: November 2017
Phase: N/A
Study type: Observational

This pilot study is intended to identify sex differences in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS) during recovery from brief but high effort exercise tests. It is expected that women with ME/CFS as compared to males with ME/CFS will show slower recovery from exercise with respect to heart rate and blood pressure, physical functioning, and symptom severity. Also females with ME/CFS as compared to males with ME/CFS will show greater negative impacts on heart rate, blood pressure, physical functioning and symptom severity after the two exercise tests. The findings will have implications for sex differences in the pathophysiology of post-exertional malaise and activity/exercise self-management recommendations, given the expected detrimental effects of the brief intense exercise tests on patients with ME/CFS.

NCT ID: NCT03305705 Not yet recruiting - Fatigue Clinical Trials

Effect of Iron on Cerebral Dopamine Receptor Density in Non-anaemic Premenopausal Women With Low Ferritin and Fatigue

Start date: October 23, 2017
Phase: Phase 4
Study type: Interventional

This study investigates the effect of intravenous iron substitution in non-anaemic premenopausal women with iron deficiency on: - Changes in the cerebral Dopamine (DA) receptor density after iron substitution, shown by brain PET - Reduction of fatigue and other neuropsychological symptoms after iron supplementation